Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone
China Export Growth Surges in April as Global Buyers Rush to Secure Supplies
Wall Street Futures Edge Higher as Iran Tensions and AI Optimism Shape Markets
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom
Dollar Struggles to Rally Despite Strong US Data as Fed Hike Expectations Remain Limited
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit
Dell Stock Hits Record High After Trump Endorsement, AI Server Demand Fuels Rally
Continental AG Shares Jump After Q1 Profit Beats Expectations
European Stocks Edge Higher as Iran-U.S. Peace Talks Boost Market Sentiment
S&P 500, Nasdaq Hit Record Highs as AI Stocks Rally and Strong Jobs Data Boost Confidence
Iran-U.S. Peace Deal Near as Oil Prices Fall and Nuclear Disputes Persist
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments
Asian Stocks Slide as Iran Tensions Escalate Despite Strong Weekly Gains
Japan’s Yen Intervention and BOJ Rate Hike Bets Support Currency Recovery 



